News

27th October 2014

Asalus Medical Instruments strengthens management team

A Cardiff-based developer of advanced medical devices has strengthened its management team with two new appointments.

Asalus Medical Instruments has recruited Jon Lawrence as Commercial Manager and Joanne Campbell as Regulatory and Quality Affairs Manager as it continues to launch its revolutionary new technology UltravisionTM across the globe.

Jon Lawrence joins the team from MediStim ASA with over a decade of experience in medical sales, the last four of which were spent in a cardiac surgical environment. Prior to MediStim Jon worked for Olympus as a Product Specialist for surgical instruments and systems, including its range of laparoscopic instrumentation.  A multilingual sales specialist, Jon will be responsible for expanding the distribution network for Ultravision internationally.

Joanne Campbell, formerly Quality Manager at Cellnovo, is a quality professional with over 25 years of relevant experience, the majority of which has been spent working within the medical device sector. Qualified to perform audits to ISO9001, ISO13485, TS16949, AS9100, ISO14001, OHSAS 18001 and cGMP, Joanne will assume responsibility for ensuring Asalus’ products and business activities comply with the necessary regulatory requirements.

On joining Asalus, Jon said: “Asalus is already receiving overwhelming interest from the surgical community for Ultravision. I’m very aware of the problems caused by laparoscopic surgical smoke and Ultravision provides an innovative and unique means of addressing this problem. It has secured a network of distributors and I’m looking forward to expanding these connections using my experience in the industry to develop markets for this innovative product.”

The first product to be launched by Asalus, which was established to commercialise the inventions of the Welsh Institute of Minimal Access Therapy (WIMAT), Ultravision is a highly innovative means of handling the surgical smoke that is created by cutting instruments during laparoscopic surgery.

Conceived by Dr Neil Warren, a specialist at the forefront of minimally invasive surgery training, Ultravision secured the CE mark in January 2014, allowing hospitals to use the system on patients undergoing laparoscopic surgery in the European Union member states.

Since being awarded the CE mark at the beginning of the year, Asalus has secured distributors to supply the laparoscopic surgical smoke handling system to hospitals across Europe, the Middle East, New Zealand and Australia.

Dominic Griffiths, Managing Director of Asalus, said: “Jon and Joanne join us at a crucial in the business as we continue to roll out Ultravision across the globe. We know that with approximately six million laparoscopic procedures performed each year globally, there is a huge market for Ultravision. Both Jon and Joanne have the necessary skills, contacts and experience to enhance our team and support us with our ambitious growth plans.”

Media enquiries to Lyndsey Jenkins at jamjar PR on 01446 771265 or lyndsey@jamjar-pr.co.uk

About Asalus

Asalus was established by Fusion IP PLC, now IP Group, in 2009 to commercialise the inventions from Cardiff University’s Welsh Institute of Minimal Access Therapy (WIMAT).  Both Asalus and WIMAT are based at the Cardiff Medicentre which is on the University Hospital Wales campus, Cardiff.  Asalus is privately funded by Finance Wales Ltd and IP Group PLC. www.asalus.com